Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.
Since Nov 17, 2025
Transactions
21
Purchases
0
Sales
21
Purchase value
$0.00
Sale value
$351.41K
Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.
Kristin AbateChief Accounting Officer
4
Filed Oct 19, 2026Period of report Oct 16, 20260001193125-26-425227
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleOct 16, 2026
Common StockF1
4,788
$0.344
$1.65K
18,616
Direct
Filing footnotes · 1
F1This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on May 27, 2021, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person.
Filed Oct 2, 2026Period of report Oct 1, 20260001193125-26-412209
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleOct 1, 2026
Common StockF1
378
$1.19
$449.82
23,404
Direct
Filing footnotes · 1
F1This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on May 27, 2021, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person.
Filed Sep 2, 2026Period of report Sep 1, 20260001193125-26-380404
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleSep 1, 2026
Common StockF1
19
$2.02
$38.38
23,782
Direct
Filing footnotes · 1
F1This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on May 27, 2021, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person.
Filed Jul 30, 2026Period of report Jul 28, 20260001193125-26-326290
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleJul 28, 2026
Common StockF1
189
$7.10
$1.34K
94,632
Direct
Filing footnotes · 1
F1This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on May 18, 2022, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person.
Filed May 15, 2026Period of report May 13, 20260001193125-26-226697
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleMay 14, 2026
Common StockF2
403
$9.50
$3.83K
94,821
Direct
Filing footnotes · 2
F1Represents the number of shares of the issuer's common stock underlying performance-based restricted stock units ("PSUs") granted in February 2024 that have been earned based on the level of achievement of the clinical milestone for complete enrollment in the Company's Phase 3 XPORT-EC-042 trial, as certified by the issuer's Compensation Committee on May 13, 2026. Each earned PSU represents the contingent right to receive one share of the issuer's common stock upon vesting. The earned PSUs vested on May 13, 2026.
F2This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on May 18, 2022, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of PSUs. The sale does not represent a discretionary trade by the reporting person.
Filed May 15, 2026Period of report May 13, 20260001193125-26-226685
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleMay 14, 2026
Common StockF2
408
$9.50
$3.88K
56,829
Direct
Filing footnotes · 2
F1Represents the number of shares of the issuer's common stock underlying performance-based restricted stock units ("PSUs") granted in February 2024 that have been earned based on the level of achievement of the clinical milestone for complete enrollment in the Company's Phase 3 XPORT-EC-042 trial, as certified by the issuer's Compensation Committee on May 13, 2026. Each earned PSU represents the contingent right to receive one share of the issuer's common stock upon vesting. The earned PSUs vested on May 13, 2026.
F2This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on April 4, 2022, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of PSUs. The sale does not represent a discretionary trade by the reporting person.
Filed May 15, 2026Period of report May 13, 20260001193125-26-226652
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleMay 14, 2026
Common StockF2
324
$9.50
$3.08K
107,940
Direct
Filing footnotes · 2
F1Represents the number of shares of the issuer's common stock underlying performance-based restricted stock units ("PSUs") granted in February 2024 that have been earned based on the level of achievement of the clinical milestone for complete enrollment in the Company's Phase 3 XPORT-EC-042 trial, as certified by the issuer's Compensation Committee on May 13, 2026.
F2This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on June 7, 2022, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of PSUs. The sale does not represent a discretionary trade by the reporting person.
Filed May 15, 2026Period of report May 13, 20260001193125-26-226616
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleMay 14, 2026
Common StockF3
53
$9.50
$503.50
23,801
Direct
Filing footnotes · 3
F1Represents the number of shares of the issuer's common stock underlying performance-based restricted stock units ("PSUs") granted in February 2024 that have been earned based on the level of achievement of the clinical milestone for complete enrollment in the Company's Phase 3 XPORT-EC-042 trial, as certified by the issuer's Compensation Committee on May 13, 2026. Each earned PSU represents the contingent right to receive one share of the issuer's common stock upon vesting. The earned PSUs vested on May 13, 2026.
F2Includes 1,670 shares acquired by the reporting person under the Karyopharm Therapeutics Inc. 2013 Employee Stock Purchase Plan, as amended, on April 30, 2026.
F3This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on May 27, 2021, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of PSUs. The sale does not represent a discretionary trade by the reporting person.
Filed May 15, 2026Period of report May 13, 20260001193125-26-226613
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleMay 14, 2026
Common StockF2
2,203
$9.50
$20.93K
269,747
Direct
Filing footnotes · 2
F1Represents the number of shares of the issuer's common stock underlying performance-based restricted stock units ("PSUs") granted in February 2024 that have been earned based on the level of achievement of the clinical milestone for complete enrollment in the Company's Phase 3 XPORT-EC-042 trial, as certified by the issuer's Compensation Committee on May 13, 2026. Each earned PSU represents the contingent right to receive one share of the issuer's common stock upon vesting. The earned PSUs vested on May 13, 2026.
F2This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on June 10, 2021, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of PSUs. The sale does not represent a discretionary trade by the reporting person.
Filed May 15, 2026Period of report May 13, 20260001193125-26-226604
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleMay 14, 2026
Common StockF2
266
$9.50
$2.53K
94,398
Direct
Filing footnotes · 2
F1Represents the number of shares of the issuer's common stock underlying performance-based restricted stock units ("PSUs") granted in February 2024 that have been earned based on the level of achievement of the clinical milestone for complete enrollment in the Company's Phase 3 XPORT-EC-042 trial, as certified by the issuer's Compensation Committee on May 13, 2026. Each earned PSU represents the contingent right to receive one share of the issuer's common stock upon vesting. The earned PSUs vested on May 13, 2026.
F2This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on May 16, 2022, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of PSUs. The sale does not represent a discretionary trade by the reporting person.
Filed Apr 22, 2026Period of report Apr 21, 20260001825322-26-000006
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleApr 21, 2026
Common StockF1
449
$8.94
$4.01K
56,290
Direct
Filing footnotes · 1
F1This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on April 4, 2022, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person.
Filed Mar 3, 2026Period of report Mar 2, 20260002045943-26-000003
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleMar 2, 2026
Common StockF1
559
$9.4095
$5.26K
22,063
Direct
Filing footnotes · 1
F1This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on May 27, 2021, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person.
Filed Mar 3, 2026Period of report Mar 2, 20260001942597-26-000003
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleMar 2, 2026
Common StockF1
5,101
$9.4095
$48.00K
94,328
Direct
Filing footnotes · 1
F1This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on May 18, 2022, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person.
Filed Mar 3, 2026Period of report Mar 2, 20260001865796-26-000003
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleMar 2, 2026
Common StockF1
4,604
$9.4095
$43.32K
107,317
Direct
Filing footnotes · 1
F1This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on June 7, 2022, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person.
Filed Mar 3, 2026Period of report Mar 2, 20260001837741-26-000003
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleMar 2, 2026
Common StockF1
3,526
$9.4095
$33.18K
93,964
Direct
Filing footnotes · 1
F1This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on May 16, 2022, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person.
Filed Mar 3, 2026Period of report Mar 2, 20260001825322-26-000003
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleMar 2, 2026
Common StockF1
5,066
$9.4095
$47.67K
56,739
Direct
Filing footnotes · 1
F1This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on April 4, 2022, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person.
Filed Mar 3, 2026Period of report Mar 2, 20260001804460-26-000003
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleMar 2, 2026
Common StockF1
12,361
$9.4095
$116.31K
267,030
Direct
Filing footnotes · 1
F1This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on June 10, 2021, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person.
Filed Feb 19, 2026Period of report Feb 17, 20260001193125-26-059332
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleFeb 17, 2026
Common StockF1
378
$8.63
$3.26K
99,429
Direct
Filing footnotes · 1
F1This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on May 18, 2022, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person.
Filed Feb 4, 2026Period of report Feb 3, 20260001193125-26-037584
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleFeb 3, 2026
Common StockF1
1,626
$6.30
$10.24K
85,105
Direct
Filing footnotes · 1
F1This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on December 19, 2024, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person.
Filed Jan 29, 2026Period of report Jan 27, 20260001193125-26-029599
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleJan 28, 2026
Common StockF2
50
$7.03
$351.50
22,622
Direct
Filing footnotes · 2
F1Represents the number of shares of the issuer's common stock underlying performance-based restricted stock units ("PSUs") granted in February 2023 that have been earned based on the level of achievement of the revenue and total shareholder return milestones as certified by the issuer's Compensation Committee on January 27, 2026. Each earned PSU represents the contingent right to receive one share of the issuer's common stock upon vesting. The earned PSUs vested on January 27, 2026.
F2This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on May 27, 2021, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of PSUs. The sale does not represent a discretionary trade by the reporting person.
Filed Jan 22, 2026Period of report Jan 21, 20260001193125-26-019428
Transaction
Security
Shares
Price
ValueValue (shares × price)
Held after
Ownership
SaleJan 21, 2026
Common StockF1
265
$5.96
$1.58K
22,580
Direct
Filing footnotes · 1
F1This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on May 27, 2021, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person.
P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.